I want to find


Cutting-edge Technology for Advanced Prostate Cancer Detection Introduced at Monmouth Medical Center, Southern Campus

Lakewood, NJ – An advanced technology to more accurately diagnose prostate cancer has been introduced at Monmouth Medical Center, Southern Campus (MMCSC).

MRI ultrasound fusion biopsy is a new method to test suspected prostate tumors by fusing MRI images of the prostate with ultrasound images. This approach offers a direct, guided approach to suspicious lesions on the prostate, resulting in more accurate results.

“Combining MRI and ultrasound technology allows physicians to better determine the stages of prostate cancer and whether a certain case is high or low-risk,” says Mukaram Gazi, MD, FACS, Chief of Urology at MMCSC. “Having access to such clear-cut data yields better treatment options for patients since physicians can be more certain whether a case will call for a watch-and-wait approach, surgical intervention, or radiation therapy.”

In the past, finding the exact location of cancer in the prostate has been challenging, according to Dr. Gazi, who says that while the traditional approach involved ultrasound, it was without the enhanced visualization offered by the MRI fusion technology. This technology offers cutting-edge visualization and prostate cancer detection, he said.

“I find the easiest way to explain this approach is to compare it to using a GPS rather than road signs,” Dr. Gazi said. “Both options are going to get you to your destination but the GPS will get you there quicker and more efficiently. In the past, specific lesions weren’t always captured by ultrasound alone. Now, being able to overlay the MRI image with the ultrasound, we’ll know exactly what we’re looking for and where to find it.”

The ideal patients for a MRI fusion biopsy at MMCSC would be men with elevated or rising prostate-specific antigen (PSA) levels or those who have a clinical concern for prostate cancer, stated Kiritkumar Pandya, MD, Urologist and President of the MMCSC Medical Staff. This includes men who may have had a previous negative biopsy result, an abnormal rectal exam, or have been diagnosed with prostate cancer but have been given a watch-and-wait treatment plan.

“We are proud to introduce this state-of-the-art technology to Ocean County,” said Frank J. Vozos, MD, FACS, Executive Vice President, RWJBarnabas Health and Chief Executive, MMCSC. “Men in our community now have access to the newest innovation in prostate cancer detection through our team of urologists at Monmouth South, proving that you don’t have to travel far to receive the most advanced prostate cancer care.”

The two-step procedure is performed on an outpatient basis, and patients must first be evaluated by an urologist to determine if they are a candidate for this type of biopsy. For more information or to schedule an appointment with a MMCSC urologist, call 1.888.724.7123.

About Monmouth Medical Center, Southern Campus
Monmouth Medical Center, Southern Campus is an acute-care community hospital located in Lakewood, Ocean County. An RWJBarnabas Health facility, Monmouth Medical Center, Southern Campus merged with Monmouth Medical Center, a teaching hospital located in Long Branch, Monmouth County, in 2014. The hospitals are dedicated to improving the health and well-being of the communities they proudly serve through expanded access to specialty outpatient services that focus on preventive medicine and healthy living. The partnership has also expanded patients' access to geriatric and pediatric emergency services, as well as outpatient neurology, oncology and geriatric services. Monmouth Medical Center, Southern Campus has converted to all private rooms, which makes it the only provider in the region with all private rooms for overnight stays. For more information about Monmouth Medical Center, Southern Campus, visit here.

CONTACT: Megan Granozio